ARCHIVES

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

This article is from The Cancer Letter archive.

Vol. 31 No. 20 | May 20, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: White House Appoints Six to NCAB; Calabrisi To Succeed Korn As Chairman; 2 Spaces Vacant

January 25, 1991

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

In Brief: NCI Anniversary Party Moved To May 26; Patricia Randall Heads Women Radiologists

February 27, 1987

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997